Jiny Kim - Apr 5, 2022 Form 4 Insider Report for Cytosorbents Corp (CTSO)

Role
Director
Signature
/s/ Kathleen P. Bloch attorney-in-fact for Jiny Kim
Stock symbol
CTSO
Transactions as of
Apr 5, 2022
Transactions value $
$0
Form type
4
Date filed
4/5/2022, 07:17 PM
Previous filing
Apr 5, 2022
Next filing
Aug 12, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CTSO Common Stock Award $0 +69.3K $0.00 69.3K Apr 5, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CTSO Stock Option (Right to Buy) Award $0 +17.3K $0.00 17.3K Apr 5, 2022 Common Stock 17.3K $3.09 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares represent restricted stock units ("RSUs") that will be settled into shares of the Issuer's common stock upon vesting upon a "Change In Control" of the Issuer as defined in the Amended and Restated CytoSorbents Corporation 2014 Long-Term Incentive Plan (the "Plan").
F2 Reflects the grant of a stock option to purchase 17,250 shares of the Issuer's common stock, which will vest in four quarterly installments from the date of grant and becoming fully vested on the first anniversary of the date of grant, subject to the Reporting Person's continued service on the applicable vesting date.